Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer.
Oudard S, Banu E, Beuzeboc P, Voog E, Dourthe LM, Hardy-Bessard AC, Linassier C, Scotté F, Banu A, Coscas Y, Guinet F, Poupon MF, Andrieu JM. Oudard S, et al. Among authors: beuzeboc p. J Clin Oncol. 2005 May 20;23(15):3343-51. doi: 10.1200/JCO.2005.12.187. Epub 2005 Feb 28. J Clin Oncol. 2005. PMID: 15738542 Clinical Trial.
Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.
Launay-Vacher V, Oudard S, Janus N, Gligorov J, Pourrat X, Rixe O, Morere JF, Beuzeboc P, Deray G; Renal Insufficiency and Cancer Medications (IRMA) Study Group. Launay-Vacher V, et al. Among authors: beuzeboc p. Cancer. 2007 Sep 15;110(6):1376-84. doi: 10.1002/cncr.22904. Cancer. 2007. PMID: 17634949 Free article.
[Chemotherapy for prostate cancer].
Medioni J, Dionysopoulos D, Banu E, Scotté F, Beuzeboc P, Oudard S. Medioni J, et al. Among authors: beuzeboc p. Presse Med. 2008 May;37(5 Pt 2):814-20. doi: 10.1016/j.lpm.2007.07.019. Epub 2007 Dec 21. Presse Med. 2008. PMID: 18160251 Review. French.
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues.
Launay-Vacher V, Gligorov J, Le Tourneau C, Janus N, Spano JP, Ray-Coquard I, Oudard S, Pourrat X, Morere JF, Deray G, Beuzeboc P; Renal Insufficiency and Anticancer Medications (IRMA) Study Group. Launay-Vacher V, et al. Among authors: beuzeboc p. Breast Cancer Res Treat. 2010 Dec;124(3):745-53. doi: 10.1007/s10549-008-0131-1. Epub 2008 Aug 15. Breast Cancer Res Treat. 2010. PMID: 18704681
Lung cancer and renal insufficiency: prevalence and anticancer drug issues.
Launay-Vacher V, Etessami R, Janus N, Spano JP, Ray-Coquard I, Oudard S, Gligorov J, Pourrat X, Beuzeboc P, Deray G, Morere JF; Renal Insufficiency Anticancer Medications (IRMA) Study Group. Launay-Vacher V, et al. Among authors: beuzeboc p. Lung. 2009 Jan-Feb;187(1):69-74. doi: 10.1007/s00408-008-9123-5. Epub 2008 Oct 22. Lung. 2009. PMID: 18941834
Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA study.
Launay-Vacher V, Spano JP, Janus N, Gligorov J, Ray-Coquard I, Oudard S, Pourrat X, Morere JF, Beuzeboc P, Deray G; Renal Insufficiency and Anticancer Medications (IRMA) Study Group. Launay-Vacher V, et al. Among authors: beuzeboc p. Crit Rev Oncol Hematol. 2009 May;70(2):124-33. doi: 10.1016/j.critrevonc.2008.09.012. Epub 2008 Nov 5. Crit Rev Oncol Hematol. 2009. PMID: 18990585
Phase II trial of consolidation docetaxel and samarium-153 in patients with bone metastases from castration-resistant prostate cancer.
Fizazi K, Beuzeboc P, Lumbroso J, Haddad V, Massard C, Gross-Goupil M, Di Palma M, Escudier B, Theodore C, Loriot Y, Tournay E, Bouzy J, Laplanche A. Fizazi K, et al. Among authors: beuzeboc p. J Clin Oncol. 2009 May 20;27(15):2429-35. doi: 10.1200/JCO.2008.18.9811. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364971 Clinical Trial.
261 results